David Shaw’s Translational Development Acquisition Corp Units TDACU Stock Holding History

David Shaw’s Portfolio TDACU Stock Details TDACU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-350,000	Closed	-$3.69M	–	5314
2026 Q1	$3.69M	Hold	350,000	–	–	﹤0.01%	2402
2025 Q4	$3.69M	Hold	350,000	–	–	﹤0.01%	2563
2025 Q3	$3.64M	Hold	350,000	–	–	﹤0.01%	2491
2025 Q2	$3.6M	Hold	350,000	–	–	﹤0.01%	2278
2025 Q1	$3.55M	Hold	350,000	–	–	﹤0.01%	2159
2024 Q4	$3.51M	Buy	+350,000	New	+$3.51M	﹤0.01%	2270

Other funds holding TDACU

Clear Street New York $39.5B AUM 124.03% 1-Year Est. Return

FTUS

Flow Traders U.S. New York $2.43B AUM 44.44% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

David Shaw's TDACU Position: Q2 2026 in Review

David Shaw sold out of Translational Development Acquisition Corp Units (TDACU) in Q2 2026, closing a stake of 350,000 shares — an estimated $3.69M sold.

David Shaw first reported a position in TDACU in Q4 2024 and held it in 6 quarters. The position peaked at $3.69M in Q1 2026. 3 funds tracked by Wall St. Rank hold TDACU as of Q2 2026.

David Shaw reported no remaining Translational Development Acquisition Corp Units position as of Q2 2026 after selling out during the quarter.
David Shaw sold 350,000 Translational Development Acquisition Corp Units shares in Q2 2026, an estimated $3.69M.
David Shaw first reported a position in Translational Development Acquisition Corp Units in Q4 2024 and held it in 6 quarters.
David Shaw's Translational Development Acquisition Corp Units position peaked at $3.69M in Q1 2026.
3 funds tracked by Wall St. Rank held Translational Development Acquisition Corp Units as of Q2 2026.

Based on D.E. Shaw & Co's 13F filing for Q2 2026, filed 14 Aug 2026.